Pilot Centers for Precision Disease Modeling (U54)(Clinical Trials Not Allowed)
Funding Opportunity PAR-20-085 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites U54 cooperative agreement applications for Pilot Centers for Precision Disease Modeling. The goal of the Centers is to support collaborative research projects that link current personalized medicine efforts in human subjects with advances in animal genomics and technologies for genetic manipulation and creation of interspecies somatic hybrids. Functionally linking these areas of research will produce programs to enhance the predictive value of preclinical studies based on the use of precision a...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 8, 2020 Category: Research Source Type: funding
Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed)
Funding Opportunity RFA-OD-20-002 from the NIH Guide for Grants and Contracts. This FOA encourages grant applications for national Animal and Biological Material Resource Centers. These Centers provide support for special colonies of laboratory animals, as well as other resources such as informatics tools, reagents, cultures (cells, tissues, and organs) and genetic stocks that serve the biomedical research community in a variety of research areas on a local, regional, and national basis. The important mission of the projects described by this FOA is to provide research resources, which are facilitating the optimization ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 8, 2020 Category: Research Source Type: funding
Developmental Mechanisms of Human Structural Birth Defects (P01 Clinical Trial Not Allowed))
Funding Opportunity RFA-HD-21-013 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support innovative, multidisciplinary, interactive, and synergistic program projects that integrate basic, translational, and clinical approaches to understanding the developmental biology and genetic basis of significant congenital human malformations. To contain costs, each program project will consist of only three component research projects, as well as associated cores. At least one project must use basic research in an animal model system and at least one project must be c...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 17, 2019 Category: Research Source Type: funding
Type 1 Diabetes in Acute Pancreatitis Consortium - Clinical Centers (T1DAPC-CCs) (U01 Clinical Trial Optional)
Funding Opportunity RFA-DK-19-022 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits U01 applications for the establishment of a clinical consortium, composed of one Data Coordinating Center (DCC) and up to 10 Clinical Centers (CC), to conduct studies on diabetes mellitus, with an emphasis on Type 1 diabetes (T1D), that occurs after or as a consequence of one or more episodes of acute pancreatitis. The Consortium will form multi-disciplinary teams composed of members from the CCs and DCC to undertake a prospective longitudinal observational study of the occurrence of diabet...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 9, 2019 Category: Research Source Type: funding
Type 1 Diabetes in Acute Pancreatitis Consortium - Data Coordinating Center (T1DAPC-DCC) (U01 Clinical Trial Optional)
Funding Opportunity RFA-DK-19-023 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits U01 applications for the establishment of a clinical consortium, the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC), composed of one Data Coordinating Center (DCC) and up to 10 Clinical Centers (CC), to conduct studies on Type 1 diabetes mellitus (T1D) that occurs after or as a consequence of one or more episodes of acute pancreatitis. Applications for the Clinical Centers (CC) are submitted in response to a separate FOA: RFA-DK-19-022: Type 1 Diabetes in Acute Pancreatitis Conso...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 9, 2019 Category: Research Source Type: funding
Type 1 Diabetes in Acute Pancreatitis Consortium - Clinical Centers (T1DAPC-CCs) (U01 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) solicits U01 applications for the establishment of a clinical consortium, composed of one Data Coordinating Center (DCC) and up to 10 Clinical Centers (CC), to conduct studies on diabetes mellitus, with an emphasis on Type 1 diabetes (T1D), that occurs after or as a consequence of one or more episodes of acute pancreatitis. The Consortium will form multi-disciplinary teams composed of members from the CCs and DCC to undertake a prospective longitudinal observational study of the occurrence of diabetes that occurs during an acute pancreatitis episode or subsequently, with an empha...
Source: NIDDK Funding Opportunities - December 9, 2019 Category: Endocrinology Source Type: funding
Type 1 Diabetes in Acute Pancreatitis Consortium - Data Coordinating Center (T1DAPC-DCC) (U01 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) solicits U01 applications for the establishment of a clinical consortium, the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC), composed of one Data Coordinating Center (DCC) and up to 10 Clinical Centers (CC), to conduct studies on Type 1 diabetes mellitus (T1D) that occurs after or as a consequence of one or more episodes of acute pancreatitis. Applications for the Clinical Centers (CC) are submitted in response to a separate FOA: RFA-DK-19-022: Type 1 Diabetes in Acute Pancreatitis Consortium Clinical Centers (T1DAPC-CC) (U01). The applicant for the Data Coordinating ...
Source: NIDDK Funding Opportunities - December 9, 2019 Category: Endocrinology Source Type: funding
New Approaches for Incorporating Genetic Diversity into Toxicity Testing (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-20-008 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports Phase I (R43), Direct to Phase II (R44), and Fast Track (R44) Small Business Innovative Research (SBIR) grant proposals from small businesses concerns (SBCs) to develop resources and approaches, including panels of cells or model organisms, that can better reflect the variability in human populations in chemical toxicity testing. Current toxicology testing is often limited to studies conducted in a small number of laboratory rodent strains, which can fail to identify clinically relevant tox...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 27, 2019 Category: Research Source Type: funding
Fine-Mapping Genome-Wide Associated Loci to Identify Proximate Causal Mechanisms of Serious Mental Illness (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-MH-21-100 from the NIH Guide for Grants and Contracts. Genome-wide association studies (GWAS) have identified statistical relationships between tens of thousands of common single nucleotide variants and over a thousand traits. Due to the correlated nature of nearby genetic variants, GWAS implicate regions of the genome and do not necessarily pinpoint the causal variant(s), gene(s) or mechanism(s) underlying the trait association. The purpose of this funding opportunity announcement is to support systematic fine-mapping of genome-wide significant risk loci associated with serious mental illnesses ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 27, 2019 Category: Research Source Type: funding
Small Research Grants for Establishing Basic Science-Clinical Collaborations to Understand Structural Birth Defects (R03 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-065 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to promote initial establishment of basic science-clinical collaborations by providing small grants to teams of basic scientists, physician scientists, and/or clinicians. These interdisciplinary teams may include but are not limited to the following: developmental biologists, cell biologists, geneticists, genomicists, physician scientists including individuals with DVM/VMD degrees, clinicians, epidemiologists, biostatisticians, and/or bioinformaticists. (Source: NIH Funding Opportunit...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 25, 2019 Category: Research Source Type: funding
NIDCR Research Grants for Analyses of Existing Genomics Data (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-045 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to announce support for meritorious research projects that address research questions relevant to human dental, oral, or craniofacial (DOC) conditions or traits through analyzing existing and publicly available genomics data using statistical and computational approaches. Data analysis of each project can be performed using exiting and/or novel methods to be developed in the same project, including machine learning-based methods (ML). In addition to analysis of existing data, experimental or in silico work should be pr...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 8, 2019 Category: Research Source Type: funding
Communication and Decision Making for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Optional)
Funding Opportunity RFA-CA-20-006 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative (https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative) that is intended to accelerate cancer research. The purpose of this FOA is to develop, test, and evaluate interventions and implementation approaches, or adapt existing approaches, to improve patient/provider/family risk communication and decision making for individuals and families with an inherited susceptibility to cancer. Specifically, this FOA targets the f...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 30, 2019 Category: Research Source Type: funding
Notice of Special Interest (NOSI) of NIDCR in Supporting Discovery, Characterization, and Mechanistic Study of Genetic Variants Underlying Dental, Oral, and Craniofacial Diseases and Conditions
Notice NOT-DE-19-016 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 29, 2019 Category: Research Source Type: funding
Notice of Change to Application Instructions for RFA-DK-17-018 "Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R21 - Clinical Trial Optional)"
Notice NOT-DK-20-005 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 17, 2019 Category: Research Source Type: funding
Notice to Extend the Due Date for Responses to NOT-AG-19-045 Request for Information (RFI): Need for Biologic Reagents, Imaging, Genetic and Cognitive Behavioral Assessment Tools to Facilitate the Use of Marmosets in Biomedical Research
Notice NOT-AG-20-001 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 16, 2019 Category: Research Source Type: funding
